Search

Your search keyword '"King, C"' showing total 10,099 results

Search Constraints

Start Over You searched for: Author "King, C" Remove constraint Author: "King, C"
10,099 results on '"King, C"'

Search Results

2. In-Flight Performance of Spider's 280 GHz Receivers

6. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

16. Conceptual Design of the Modular Detector and Readout System for the CMB-S4 survey experiment

17. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype

20. A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

21. Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection

22. A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.

23. A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

26. Scholarly Communication and Peer Review: Moving towards Utopia. Research & Occasional Paper Series: CSHE.4.19

28. A History of Berkeley Chemical Engineering: Pairing Engineering and Science

30. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

34. Oxygen-16 Spectrum from Tetrahedral Vibrations and their Rotational Excitations

35. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

36. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

37. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230

38. Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

40. A PKA inhibitor motif within SMOOTHENED controls Hedgehog signal transduction

41. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

42. POS1200 MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL

43. P228 Multicentre reviewof lung microbiome for patients with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

44. Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats

45. The University of California: Creating, Nurturing, and Maintaining Academic Quality in a Public University Setting

46. Involutions and the Gelfand character

47. Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults

49. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Catalog

Books, media, physical & digital resources